Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 7686-7697

  Deng, X ^a   Liu, P ^a   Zhao, Y ^a   Wang, Q ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CEACAM6; Gastric adenocarcinoma; Molecular marker; RQ PCR; Tumorigenesis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; MESSENGER RNA; TUMOR MARKER; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; PRIMER DNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CEACAM6 GENE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; SURVIVAL TIME; TISSUE DISTRIBUTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; ADENOCARCINOMA; DISEASE COURSE; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD; BASE SEQUENCE; CELL ADHESION MOLECULES; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; GENE EXPRESSION PROFILING; GPI-LINKED PROTEINS; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907833702     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.September.26.6     Document Type: Article

References (39)

1. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, et al. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26: 561-569.
2. American Joint Committee on Cancer (2002). Extrahepatic Bile Ducts. In: AJCC Cancer Staging Manual, 6th edn Springer, New York, 145-150.
3. Arrieta O, Saavedra-Perez D, Kuri R, Aviles-Salas A, et al. (2009). Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis. BMC Cancer 9: 119.
4. Blumenthal RD, Hansen HJ and Goldenberg DM (2005). Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (carcinoembryonic antigen). Cancer Res. 65: 8809-8817.
5. Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, et al. (2006). Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocr. Relat. Cancer 13: 541-558.
6. Chan CH, Cook D and Stanners CP (2006). Increased colon tumor susceptibility in azoxymethane treated CEABAC transgenic mice. Carcinogenesis 27: 1909-1916.
7. Chen J, Chen MH, Röcken C, Götze T, et al. (2003). Molecular therapy of gastric cancer. Cancer Ther. 1: 323-333.
8. Chevinsky AH (1991). CEA in tumors of other than colorectal origin. Semin. Surg. Oncol. 7: 162-166.
9. Duxbury MS, Ito H, Zinner MJ, Ashley SW, et al. (2004a). CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 23: 465-473.
10. Duxbury MS, Ito H, Benoit E, Zinner MJ, et al. (2004b). Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness. Oncogene 23: 5834-5842.
11. Duxbury MS, Ito H, Ashley SW and Whang EE (2004c). c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components. Biochem. Biophys. Res. Commun. 317: 133-141.
12. Duxbury MS, Ito H, Benoit E, Waseem T, et al. (2004d). A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res. 64: 3987-3993.
13. Duxbury MS, Ito H, Ashley SW and Whang EE (2004e). CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J. Biol. Chem. 279: 23176-23182.
14. Duxbury MS, Ito H, Benoit E, Ashley SW, et al. (2004f). CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br. J. Cancer 91: 1384-1390.
15. Duxbury MS, Matros E, Clancy T, Bailey G, et al. (2005). CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann. Surg. 241: 491-496.
16. Fenoglio-Preiser C, Munoz N, Carneiro F and Powell SM (2000). Gastric Cancer. In: Tumors of the Digestive System. Lyon: World Health Organization Classification of Tumors, Pathology & Genetics (Hamilton SR and Aaltonen LA, eds.). IARC Press, Lyon, 37-67.
17. Gaglia P, Caldarola B, Bussone R, Potente F, et al. (1988). Prognostic value of CEA and ferritin assay in breast cancer: a multivariate analysis. Eur. J. Cancer Clin. Oncol. 24: 1151-1155.
18. Genega EM, Hutchinson B, Reuter VE and Gaudin PB (2000). Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod. Pathol. 13: 1186-1191.
19. Hammarstrom S, Olsen A, Teglund S and Baranov V (1980). The Nature and Expression of the Human CEA Family. In: Cell Adhesion and Communication Mediated by the CEA Family: Basic and Clinical Perspectives (Stanners CP, ed.). Harwood Academic Publishers, Amsterdam, 1-30.
20. Hasegawa T, Isobe K, Tsuchiya Y, Oikawa S, et al. (1993). Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer. Br. J. Cancer 67: 58-65.
21. Ieta K, Tanaka F, Utsunomiya T, Kuwano H, et al. (2006). CEACAM6 gene expression in intrahepatic cholangiocarcinoma. Br. J. Cancer 95: 532-540.
22. Ilantzis C, DeMarte L, Screaton RA and Stanners CP (2002). Deregulated expression of the human tumor marker CEAand CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 4: 151-163.
23. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, et al. (2003). Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J. Clin. Oncol. 21: 3638-3646.
24. Jass JR (2005). Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat. Clin. Pract. Oncol. 2: 398-405.
25. Jass JR, Whitehall VL, Young J and Leggett BA (2002). Emerging concepts in colorectal neoplasia. Gastroenterology 123: 862-876.
26. Kawamura T, Endo Y, Yonemura Y, Nojima N, et al. (2001). Significance of integrin alpha2/beta1 in peritoneal dissemination of a human gastric cancer xenograft model. Int. J. Oncol. 18: 809-815.
27. Kim S, Peng Z and Kaneda Y (2008). Current status of gene therapy in Asia. Mol. Ther. 16: 237-243.
28. Logsdon CD, Simeone DM, Binkley C, Arumugam T, et al. (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res. 63: 2649-2657.
29. Matsuoka T, Hirakawa K, Chung YS, Yashiro M, et al. (1998). Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer. Clin. Exp. Metastasis 16: 381-388.
30. Moss SF, Lee JW, Sabo E, Rubin AK, et al. (2008). Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: influence of tumor histology and relationship to prognosis. Clin. Cancer Res. 14: 4161-4167.
31. Ogawa K, Utsunomiya T, Mimori K, Tanaka F, et al. (2005). Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin. Cancer Res. 11: 2889-2893.
32. Olnes MJ and Erlich R (2004). A review and update on cholangiocarcinoma. Oncology 66: 167-179.
33. Ordonez C, Screaton RA, Ilantzis C and Stanners CP (2000). Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res. 60: 3419-3424.
34. Ordonez C, Zhai AB, Camacho-Leal P, DeMarte L, et al. (2007). GPI-anchored CEA family glycoproteins CEA and CEACAM6 mediate their biological effects through enhanced integrin alpha5beta1-fibronectin interaction. J. Cell Physiol. 210: 757-765.
35. Soeth E, Wirth T, List HJ, Kumbhani S, et al. (2001). Controlled ribozyme targeting demonstrates an antiapoptotic effect of carcinoembryonic antigen in HT29 colon cancer cells. Clin. Cancer Res. 7: 2022-2030.
36. Thompson JA, Grunert F and Zimmermann W (1991). Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5: 344-366.
37. Wang Y, Gangeswaran R, Zhao X, Wang P, et al. (2009). CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. J. Clin. Invest. 119: 1604-1615.
38. Yasui W, Oue N, Ito R, Kuraoka K, et al. (2004). Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci. 95: 385-392.
39. Zhao ZS, Li L, Wang HJ and Wang YY (2011). Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer. J. Surg. Oncol. 104: 525-529.